BREAKING: New Blood Test for Early Alzheimer’s Detection By alice Thompson | LOS ANGELES – 2025/06/04 12:41:14 A groundbreaking blood test is poised to transform the detection of… The post Early Alzheimer’s Detection: New Blood Test Hopeful appeared first on NewsyList. Source link
The new tool comes as Alzheimer’s and Brain Awareness Month kicks off in June, an annual awareness campaign led by the Alzheimer’s Association that raises awareness about Alzheimer disease and dementia, promotes brain health, and supports individuals and families affected by these. | Image credit: Carl – stock.adobe.com A new era in Alzheimer disease detection … Read more
Patients with early Alzheimer’s disease (AD) who initiated lecanemab treatment at a specialty memory clinic showed an expected and manageable side-effect profile, new research showed. “The findings are very reassuring,” Barbara Joy Snider, MD, PhD, professor of neurology, and director of the Memory Diagnostic Center and Knight ADRC Clinical Trials Unit, Washington University School of … Read more
TOPLINE: Use of nucleoside reverse transcriptase inhibitors (NRTIs), but not other medications for HIV, was associated with a significantly reduced risk for Alzheimer’s disease (AD) in an analysis of two national databases. NRTIs are antiretroviral drugs that block the activation of inflammasome. METHODOLOGY: This study included data of nearly 272,000 US individuals from two national … Read more
TOPLINE: Metabolic syndrome was associated with a 24% increased risk for young-onset dementia, defined as dementia before the age of 65 years, with stronger associations found in women vs men, younger vs older adults, and individuals with vs without depression, a new study showed. METHODOLOGY: This nationwide population-based cohort study included data from more than … Read more
For the first time, the number of Americans living with Alzheimer’s disease (AD) has surpassed 7 million, according to the Alzheimer’s Disease Facts and Figures report released this week. An estimated 7.2 million people aged 65 years or older are now living with AD, up from an estimated 6.9 million in the 2024 report. Three … Read more
A new social media trend is making headlines: Methylene blue is being touted as a cognitive booster and antiaging miracle. Influencers such as Ben Greenfield are promoting the use of this chemical to enhance brain performance, strengthen the immune system, and even prevent cancer without providing scientific evidence. Researchers have warned that methylene blue can … Read more
A novel blood test that detects a key biomarker for Alzheimer’s disease (AD) could help physicians more accurately determine the presence and track disease progression. The test measures levels of the protein MTBR-tau243 — microtubule-binding region of tau containing the residue 243 — a biomarker of tau tangles in the brain that may be a … Read more
WASHINGTON, DC — Age-related neurodegenerative disorders — motor neuron diseases, demyelinating diseases, Alzheimer’s disease, and other proteinopathies — are at an “inflection point,” said researcher Andrea R. Merchak, PhD, with a fuller understanding of disease pathophysiology but an overall dearth of effective disease-modifying treatments. And this, Merchak said at the Gut Microbiota for Health (GMFH) … Read more
A study published in Brain Communications revealed new insights into early detection of Alzheimer’s disease. Researchers have used noninvasive techniques, including near-infrared spectroscopy and electroencephalography, to examine functioning of the neurovascular unit in this disease. The study compared 19 patients with Alzheimer’s disease with 20 control individuals, revealing a significant decrease in cerebral oxygenation oscillations … Read more